Delivery Order SPE2DB22D1103-SPE2DB24FTEZ8
- Not listed
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a $1,263.90 firm fixed price delivery order contract for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML. This contract, which has a completion date of March 6, 2024, is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation and serves as a prime contractor for DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,895.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a completion date of February 1, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $1,245.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the provision of the drug AIMOVIG 140 MG/ML AUTOINJECTORML. This is a firm fixed price delivery order with a completion date of March 21, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with a potential...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 140 MG/ML autoinjectors. The delivery order has a potential value of $3,341.05 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical products from its Corporate Office division located in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 140 MG/ML AUTOINJECTORS. The contract has a potential value of $1,182.84 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 140 MG/ML AUTOINJECTOR. The $5,107.21 contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract awarded solely to...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract worth $1,391.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML. This is a firm fixed price contract with a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceuticals and medical supplies to various U.S. government agencies, including the...
- The Defense Logistics Agency (DLA) awarded a $2,559.81 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of AIMOVIG 140 MG/ML autoinjectors, with a completion date of May 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceuticals. The order has a potential value of $1,264.14 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,520.06 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The delivery order has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTEZ8Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,053.37 to Amerisourcebergen Drug Corp, through its Corporate Office division, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This delivery order has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/8/24 |